Suboptimal survival of male germ-cell tumors in southern Portugal-a population-based retrospective study for cases diagnosed in 1999 and 2000

Annals of Oncology

Volumn 22, Issue 5, 2011, Pages 1215-1220

  Passos Coelho, J L ^a   Castro Ribeiro, M ^a   Santos, E ^a   Sousa Pontes, C ^a   Brito, B ^a   Miranda, A C ^a  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

Epidemiology; Germ cell tumor; Outcomes research; Testicular cancer

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; PACLITAXEL; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG FATALITY; GERM CELL TUMOR; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; OVERALL SURVIVAL; POPULATION RESEARCH; PORTUGAL; PRIMARY TUMOR; PRIORITY JOURNAL; RETROPERITONEAL CANCER; RETROPERITONEAL TUMOR; RETROPERITONEUM; RETROSPECTIVE STUDY; SEMINOMA; STOMACH; TESTIS; TESTIS CANCER; TESTIS NONSEMINOMA CANCER;

EID: 79955492373     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq551     Document Type: Article

References (18)

1. Schottenfeld D, Warshauer ME, Sherlock S et al. The epidemiology of testicular cancer in young adults. Am J Epidemiol 1980; 112: 232-246.
2. Devesa S, Blot W, Stone B et al. Recent cancer trends in the United States. J Natl Cancer Inst 1995; 87: 175-182.
3. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med 1997; 337: 242-253.
4. International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997; 15: 594-603.
5. Kormann KU. Treatment of testicular cancer, is quality management possible? Onkologie 2001; 24: 177-179.
6. Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Consensus Group. Eur Urol 2008; 53: 478-513.
7. Berrino F, De Angelis R, Sant M et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007; 8: 773-783.
8. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38: 933-942.
9. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5, version 2.0. Lyon: IARC Press 2004.
10. Bokemeyer C, Schmoll HJ. Treatment of clinical stage I testicular cancer and the possible role for new biological prognostic parameters. J. Cancer Res Clin Oncol 1996; 122: 575-584.
11. Albers P, Siener R, Kliesch S et al. German Testicular Cancer Study Group. Risk factors for relapse in clinical stage I non-seminomatous testicular germ cell tumours: results of the German Testicular Cancer Study Group Trial. J Clin Oncol 2003; 21: 1505-1512.
12. National Cancer Institute. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute http://seer.cancer.gov/csr/1975_2007/ (15 July 2010, date last accessed).
13. Culine S, Hoppe S, Hennequin C et al. Management of testicular neoplasms in France and compliance with national guidelines. J Clin Oncol 2010; 28: (Suppl): 361.
14. Cullen MH, Stenning SP, Parkinson MC et al. Short-course adjuvant chemotherapy in high-risk stage I non-seminomatous germ cell tumors of the testis: a Medical Research Council report. J Clin Oncol 1996; 14: 1106-1113.
15. Oliver RTD, Mason MD, Mead JM et al. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomized trial. Lancet 2005; 366: 293-300.
16. Oliver RTD, Mead JM, Fogarty PJ et al. Radiotherapy versus carboplatin for stage I seminoma: updated analysis of the MRC/EORTC randomized trial (ISRCTN 27163214). J Clin Oncol 2008; 26(Suppl 1): 5.
17. Einhorn LH, Williams SD, Loehrer PJ et al. Evaluation of optimal duration of chemotherapy in favourable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol. J Clin Oncol 1989; 7: 387-391.
18. Hinton S, Catalano PJ, Einhorn LH et al. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors-final analysis of an intergroup trial. Cancer 2003; 97: 1869-1875.